Prevention of Insomnia in At-risk Youth

Launched by CHINESE UNIVERSITY OF HONG KONG · Jul 5, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a program to help prevent insomnia, which is trouble sleeping, in young people aged 15 to 24 who are at risk for developing this condition. The researchers want to see if a special type of therapy called cognitive behavioral therapy can help these youths sleep better compared to a control group. They hope that with positive results, this program can be widely used in the future to reduce the issues caused by insomnia.

To be eligible for the trial, participants need to be between 15 and 24 years old, and they should show some signs of insomnia—like having trouble sleeping at least once a month but not more than three times a week. It’s also important that at least one of their parents has a history of insomnia. Participants will need permission from their parents if they are under 18. Those with certain health conditions or diagnosed sleep disorders, as well as those currently receiving therapy, are not eligible. If you join the study, you will receive the cognitive behavioral therapy and will be monitored to see how it affects your sleep.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Youth aged between 15-24 years (as defined by WHO);
• • Written informed consent of participation into the study is given by youth and his/her parents if under 18 years old; In addition, individual assent will also be obtained for subjects under age 18 years old;
• • Have subclinical insomnia symptoms (at least once a month but less than 3 times/week in the past one month);
• • At least one of the biological parents with current or lifetime history of insomnia disorder as defined by DSM-V diagnostic criteria.
• Exclusion Criteria:
• • A current or past history of neuropsychiatric disorder(s);
• • A prominent medical condition or taking medication with potential side effects that may influence sleep quantity and quality;
• • Having a diagnosed sleep disorder that may potentially contribute to the disruption of sleep quantity and quality as ascertained by both Structured Diagnostic Interview for Sleep patterns and Disorders (DISP) such as insomnia, delayed sleep phase and narcolepsy, restless leg syndrome;
• • Having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt);
• • Currently receiving any structured psychotherapy;
• • With hearing or speech deficit;
• • Trans-meridian flight in the past 3 months and during the study.